Kaposi’s sarcoma (KS) is a frequent cause of morbidity and mortality in patients with human immunodeficiency virus (HIV) infection. Several characteristics of KS pose challenges for the conduct of clinical trials. Kaposi’s
James M. Pluda, MD
Advertisement
Articles by James M. Pluda, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Elucidating CAR T-Cell Candidacy for Diffuse Large B-Cell Lymphomas
2
FDA Accepts RP1 BLA Resubmission for Advanced Melanoma
3
ASCO Breakthrough 2026 Wrap-Up: Precision Oncology, AI, and Biomarkers Define the Future of Cancer Care
4
Epcoritamab/Lenalidomide Significantly Improves PFS in R/R DLBCL
5